Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer.
Saved in:
| Title: | Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. |
|---|---|
| Authors: | Strong, Randy1,2, Miller, Richard A.3, Antebi, Adam4, Astle, Clinton M.5, Bogue, Molly5, Denzel, Martin S.4, Fernandez, Elizabeth1,2, Flurkey, Kevin5, Hamilton, Karyn L.6, Lamming, Dudley W.7, Javors, Martin A.8, Magalhães, João Pedro9, Martinez, Paul Anthony1,2, McCord, Joe M.10, Miller, Benjamin F.6, Müller, Michael11, Nelson, James F.12, Ndukum, Juliet5, Rainger, G. Ed.13, Richardson, Arlan14,15 |
| Source: | Aging Cell. Oct2016, Vol. 15 Issue 5, p872-884. 13p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
